APA (7th ed.) Citation

M, E., Y, K., H, S., RV, O., & Z, A. (2011). An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers. PLoS computational biology, 7(9), e1002206. https://doi.org/10.1371/journal.pcbi.1002206

Chicago Style (17th ed.) Citation

M, Elishmereni, Kheifetz Y, Søndergaard H, Overgaard RV, and Agur Z. "An Integrated Disease/pharmacokinetic/pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers." PLoS Computational Biology 7, no. 9 (2011): e1002206. https://doi.org/10.1371/journal.pcbi.1002206.

MLA (9th ed.) Citation

M, Elishmereni, et al. "An Integrated Disease/pharmacokinetic/pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers." PLoS Computational Biology, vol. 7, no. 9, 2011, p. e1002206, https://doi.org/10.1371/journal.pcbi.1002206.